Literature DB >> 15009583

Maternal diclofenac sodium ingestion and severe neonatal pulmonary hypertension.

K L Siu1, W H Lee.   

Abstract

We describe a case of severe pulmonary hypertension and transient right-sided hypertrophic cardiomyopathy in a neonate, caused by premature closure of ductus arteriosus after short-term maternal use of diclofenac sodium (Voltaren). In view of this associated complication, diclofenac sodium should be avoided during pregnancy. In addition, maternal diclofenac sodium ingestion should be suspected if a newborn develops severe pulmonary hypertension and/or right-sided hypertrophic cardiomyoptathy with closed ductus arteriosus.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15009583     DOI: 10.1111/j.1440-1754.2004.00319.x

Source DB:  PubMed          Journal:  J Paediatr Child Health        ISSN: 1034-4810            Impact factor:   1.954


  9 in total

1.  Prenatal constriction of the ductus arteriosus following maternal diclofenac medication in the third trimester.

Authors:  Karoline Aker; Anne Brantberg; Siri Ann Nyrnes
Journal:  BMJ Case Rep       Date:  2015-10-01

2.  Maternal diclofenac medication in pregnancy causing in utero closure of the fetal ductus arteriosus and hydrops.

Authors:  Aravind T Shastri; Dalia Abdulkarim; Paul Clarke
Journal:  Pediatr Cardiol       Date:  2012-08-08       Impact factor: 1.655

3.  Prediction and evaluation of fetal toxicity induced by NSAIDs using transplacental kinetic parameters obtained from human placental perfusion studies.

Authors:  Kyohei Shintaku; Satoko Hori; Hiroki Satoh; Kiyomi Tsukimori; Hitoo Nakano; Tomoyuki Fujii; Yuji Taketani; Hisakazu Ohtani; Yasufumi Sawada
Journal:  Br J Clin Pharmacol       Date:  2012-02       Impact factor: 4.335

Review 4.  Pharmacokinetics of drugs in pregnancy.

Authors:  Maisa Feghali; Raman Venkataramanan; Steve Caritis
Journal:  Semin Perinatol       Date:  2015-11       Impact factor: 3.300

5.  A consensus approach to the classification of pediatric pulmonary hypertensive vascular disease: Report from the PVRI Pediatric Taskforce, Panama 2011.

Authors:  Maria Jesus Del Cerro; Steven Abman; Gabriel Diaz; Alexandra Heath Freudenthal; Franz Freudenthal; S Harikrishnan; Sheila G Haworth; Dunbar Ivy; Antonio A Lopes; J Usha Raj; Julio Sandoval; Kurt Stenmark; Ian Adatia
Journal:  Pulm Circ       Date:  2011       Impact factor: 3.017

6.  Prenatal exposure of diclofenac sodium alters the behavioral development of young Wistar rats.

Authors:  Birsen Elibol; Begüm Aritan Oğur; Havva Doğru
Journal:  Turk J Biol       Date:  2019-10-14

7.  Medication use among pregnant women at a secondary health institution: utilisation patterns and predictors of quantity.

Authors:  Stella T Obadeji; Adetunji Obadeji; Janet O Bamidele; Felix T Ajayi
Journal:  Afr Health Sci       Date:  2020-09       Impact factor: 0.927

8.  Severe neonatal pulmonary hypertension secondary to antenatal maternal diclofenac ingestion reversed by inhaled nitric oxide and oral sildenafil.

Authors:  Ali Mersal; Ihab Attili; Abdulaziz Alkhotani
Journal:  Ann Saudi Med       Date:  2007 Nov-Dec       Impact factor: 1.526

9.  Patterns and determinants of prescribed drug use among pregnant women in Adigrat general hospital, northern Ethiopia: a cross-sectional study.

Authors:  Niguse Meles Alema; Getachew Semagn; Shetey Melesse; Ephrem Mebrahtu Araya; Hagazi Gebremedhin; Desalegn Getnet Demsie; Solomon Weldegebreal Asgedom; Etasy Weldekidan
Journal:  BMC Pregnancy Childbirth       Date:  2020-10-15       Impact factor: 3.007

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.